News

Explore how the YB1 protein's intrinsic disorder helps it perform crucial cellular functions, impacting cancer therapies.

Researchers have uncovered a specific form of epigenetic aging that leads to the shutdown of key genes in intestinal stem cells.

Discover a simple, automated method of producing many lung organoids at once, open the door for more effective ways to trial lung disease and cancer treatments.

A study using isotope tracing metabolomics found that people with Fanconi anemia fail to use glucose efficiently, show elevated ketones and signs of insulin resistance. The findings reveal metabolic inflexibility.

Automated lung organoid production offers scalable, human-based models for testing therapies and accelerating lung disease research.

New research has identified a drug combination that can bypass the cellular defences of neuroblastoma that lead to relapse.

UCLA’s CAR-NKT therapy overcomes solid-tumor barriers, eliminating primary and metastatic pancreatic cancer in advanced preclinical models.

A new study outlines that most of the benefits of hormone therapy for prostate cancer occur in the first 9 to 12 months, and extending therapy increases the risk of health problems.

Some cancers can "shapeshift" and start to resemble cells from other organs. New research has identified the proteins involved.

A new study shows that a specific subset of mutations in the POLE gene is strongly associated with durable responses to immunotherapy in patients with metastatic colorectal cancer.